HIV-1 and the central nervous system

Current Topics in Microbiology and Immunology

Volumn 265, Issue , 2002, Pages 183-195

  Tardieu, M ^a   Boutet, A ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CHEMOKINE RECEPTOR; NEUROTOXIN; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN CELL; BRAIN DISEASE; CELL ACTIVATION; CELL FATE; CENTRAL NERVOUS SYSTEM; DEMENTIA; DISEASE MODEL; GENETIC SUSCEPTIBILITY; GLIA CELL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MICROGLIA; NEUROPATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0036130453     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-662-09525-6_9     Document Type: Review

References (49)

1. Immunologic NO synthase: Elevation in severe AIDS dementia and induction by HIV-1 gp41
2. Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage
3. Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: Identification by the combination of in situ polymerase chain reaction and immunohistochemistry
4. Direct role of plasma membrane-expressed gp120/41 in toxicity to human astrocytes induced by HIV-1-infected macrophages
5. Increased peroxynitrite activity in AIDS dementia complex: Implications for the neuropathogenesis of HIV-1 infection
6. Interactions between HIV-infected monocyte-derived macrophages and human brain microvascular endothelial cells result in increased expression of CC chemokines
7. Changing incidence of AIDSdefining illnesses in the era of antiretroviral combination therapy
8. Biophysical characterization of gp41 aggregates suggests a model for the molecular mechanism of HIV-associated neurological damage and dementia
9. Cerebrospinal fluid HIV-1 RNA levels: Correlation with HIV encephalitis
10. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia
11. HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy
12. Decreasing incidence of CNS AIDS-defining events associated with antiretroviral therapy
13. Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources
14. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome
15. Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1
16. Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine
17. HIV infection and dementia
18. Accumulation of beta-amyloid precursor protein in HIV encephalitis: Relationship with neuropsychological abnormalities
19. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia
20. Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid
21. 2) regulatory pathways
22. Induction of human immunodeficiency virus type 1 replication in human glial cells after proinflammatory cytokines stimulation: Effect of IFNgamma, IL1 beta, and TNFalpha on differentiation and chemokine production in glial cells
23. Negative feedback between prostaglandin and alpha- and beta-chemokine synthesis in human microglial cells and astrocytes
24. Synergistic effect of HIV coat protein and NMDA receptor-mediated neurotoxicity
25. Changes in pathological findings at autopsy in AIDS cases for the last 15 years
26. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders
27. Dementia in AIDS patients: Incidence and risk factors. Multicenter AIDS Cohort Study
28. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain
29. Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients
30. Measurement of viral sequences in cerebrospinal fluid of AIDS patients with cerebral white-matter lesions using polymerase chain reaction
31. Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon
32. Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: Evidence for a role of the envelope
33. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
34. Induction of cytooxygenase-2 expression during HIV-1-infected monocyte-derived macrophage and human brain microvascular endothelial cell interactions
35. Neurological outcomes in late HIV infection: Adverse impact of neurological impairment on survival and protective effect of antiviral therapy
36. Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia
37. Human immunodeficiency virus infection, inducible nitric oxide synthase expression, and microglial activation: Pathogenetic relationship to the acquired immunodeficiency syndrome dementia complex
38. Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men
39. Activation of human microglial cells by HIV-1 gp41 and Tat proteins
40. Localised IH-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV
41. HIV-1 envelope protein gp41 modulates expression of interleukin-10 and chemokine receptors on monocytes, astrocytes and neurones
42. HIV-1-related central nervous system diseases
43. HIV-1-related encephalopathy in infants compared with children and adults
44. Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment
45. Reduced prevalence of the CCR5 delta32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex
46. Nitric oxide synthase expression and apoptotic cell death in brains of AIDS and AIDS dementia patients
47. Neuropathogenesis of HIV-1 infection. Outstanding questions
48. Cytokine-stimulated, but not HIV-infected, human monocyte-derived macrophages produce neurotoxic levels of L cysteine